| Anton Wintner, MD | |
|
Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 | |
| (617) 726-2800 | |
| Not Available |
| Full Name | Anton Wintner |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | Massachusetts General Hospital, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720340243 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 270052 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Massachusetts General Hospital | Boston, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
| The General Hospital Corporation | 6507803806 | 1054 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.
A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The Vertebrate Pigmentary System: From pigment cells to disorders provides readers with fundamental knowledge of the structural and functional aspects of vertebrate pigment cells - melanophores and melanocytes - from their origin to different stages of development to related diseases.
› Verified 9 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.
A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The Vertebrate Pigmentary System: From pigment cells to disorders provides readers with fundamental knowledge of the structural and functional aspects of vertebrate pigment cells - melanophores and melanocytes - from their origin to different stages of development to related diseases.
› Verified 9 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.
A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The Vertebrate Pigmentary System: From pigment cells to disorders provides readers with fundamental knowledge of the structural and functional aspects of vertebrate pigment cells - melanophores and melanocytes - from their origin to different stages of development to related diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anton Wintner, MD Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Ph: (617) 726-2800 | Anton Wintner, MD Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 Ph: (617) 726-2800 |
News Archive
Oxford BioMedica plc, a leading gene therapy company, today announces that further analyses of the TroVax Renal Immunotherapy Survival Trial, a randomised, double-blind, placebo-controlled Phase III study, have been accepted for publication in Cancer Immunology, Immunotherapy, the official journal of the Association for Cancer Immunotherapy.
Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.
A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris (France) and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia.
Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.
The Vertebrate Pigmentary System: From pigment cells to disorders provides readers with fundamental knowledge of the structural and functional aspects of vertebrate pigment cells - melanophores and melanocytes - from their origin to different stages of development to related diseases.
› Verified 9 days ago
Brian Howard Eisner, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-3512 | |
Catherine Gu, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Bwh 75 Francis St, Boston, MA 02115 Phone: 617-732-5500 | |
Dr. Dianne E Sacco, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Dept Of Urology, Boston, MA 02114 Phone: 617-726-3760 Fax: 617-726-6131 | |
Peter Lang Steinberg, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Bidmc Division Of Urology, Rabb 440, Boston, MA 02215 Phone: 617-667-3739 | |
Richard N Yu, M.D, PH.D. Urology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Department Of Urology, Hu-390, Boston, MA 02115 Phone: 617-355-7796 | |
Dr. Quoc-dien Trinh, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 45 Francis St, Division Of Urology, Boston, MA 02115 Phone: 617-525-7350 | |
Dr. Melise A Keays, MD Urology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |